In-Process Research and Development |
6 Months Ended |
---|---|
Jun. 30, 2021 | |
Research And Development [Abstract] | |
In-Process Research and Development |
NOTE 12 – IN-PROCESS RESEARCH AND DEVELOPMENT In December 2020, the Company completed the sale of Evofosfamide which was previously classified as In-process research and development - held for sale. In connection with sale, the Company recorded a loss on assets held for sale of $2.0 million which was the difference between the carrying value and the consideration received. |
X | ||||||||||
- Definition Research development and intellectual property disclosure. No definition available.
|
X | ||||||||||
- References No definition available.
|